Загрузка...
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy
Background: Spinal muscular atrophy (SMA) is a genetic disorder that leads to progressive tetraparesis. Nusinersen is the first approved drug for the treatment of SMA and is administered via intrathecal injections. Neuromyopathic scoliosis and spondylodesis can impede lumbar punctures, thus necessit...
Сохранить в:
| Опубликовано в: : | Front Neurol |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856637/ https://ncbi.nlm.nih.gov/pubmed/31787921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.01166 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|